Accounting for successful R&D efforts is still controversial among regulators. In this article, we test the value relevance of R&D reporting on a sample of 93 French firms on a three years period (1998-2000). Empirical findings suggest that capitalized R&D is negatively associated with stock prices and stock returns. Contrary to previous studies, R&D accounting seems to act a negative signal to investors in France.
JENY, A. and JEANJEAN, T. (2005). Pertinence de l'inscription à l'actif des frais R&D : une étude empirique. Comptabilité, Contrôle, Audit, pp. 5-21.